D. Ilegbodu

The US Oncology Network US

Publications

945

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

33 total

Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

Nicholas J. Robert, Brian Leyland‐Jones, Lina Asmar, Robert J. Belt, D. Ilegbodu et al. - Journal of Clinical Oncology, 2006

Cited by 484 OpenAlex

Research Topics

Cancer Treatment and Pharmacology (18) Lung Cancer Treatments and Mutations (14) Colorectal Cancer Treatments and Studies (8) Breast Cancer Treatment Studies (6) Hepatocellular Carcinoma Treatment and Prognosis (5)

Affiliations

University of North Carolina at Chapel Hill

US 2006 - 2006

Rush University Medical Center

US 2006 - 2006

Loyola University Medical Center

US 2006 - 2004

Eli Lilly (United States)

US 2006 - 2006

Texas Oncology

US 2008 - 2004

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers

D. Ilegbodu

Publication & Citation Trends

Publications

Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back